Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Papillomavirus Infections 9Uterine Cervical Neoplasms 4Neuroendocrine Tumors 4Autoimmune Diseases 3Prostatic Neoplasms 2Neoplasms 2Abortion, Spontaneous 2Recurrence 1Ovarian Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neuroblastoma 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Myasthenia Gravis 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Temozolomide 29Bevacizumab 14Radiotherapy 12Trastuzumab 10Lomustine 9Capecitabine 8paclitaxel-Angiopep-2 conjugate 6Nivolumab 6pembrolizumab 5dabrafenib 5abemaciclib 5Radiation 5icotinib 4Surgical Procedures, Operative 4Paclitaxel 4Lapatinib 4Irinotecan 4Flucytosine 4Dianhydrogalactitol 4Corticotropin-Releasing Hormone 4Chlorotoxin 4Carboplatin 4vocimagene amiretrorepvec 3verubulin 3tucatinib 3osimertinib 3motexafin gadolinium 3XL647 3Spermine Synthase 3Radiosurgery 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Brain Neoplasms × Data Collection × Clear all
NCT04253015 2024-02-07

A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

RECORDATI GROUP

Recruiting
125 enrolled
CNS

Brain Neoplasms, Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡